Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > METHUSELAH HEALTH UK LIMITED
Company Information for

METHUSELAH HEALTH UK LIMITED

C/O THE CAMBRIDGE PARTNERSHIP LTD, THE DOROTHY HODGKIN BUILDING, BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3FH,
Company Registration Number
09209003
Private Limited Company
Active

Company Overview

About Methuselah Health Uk Ltd
METHUSELAH HEALTH UK LIMITED was founded on 2014-09-09 and has its registered office in Cambridge. The organisation's status is listed as "Active". Methuselah Health Uk Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as SMALL
Key Data
Company Name
METHUSELAH HEALTH UK LIMITED
 
Legal Registered Office
C/O THE CAMBRIDGE PARTNERSHIP LTD, THE DOROTHY HODGKIN BUILDING
BABRAHAM RESEARCH CAMPUS, BABRAHAM
CAMBRIDGE
CB22 3FH
Other companies in W1S
 
Filing Information
Company Number 09209003
Company ID Number 09209003
Date formed 2014-09-09
Country UNITED KINGDOM
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 30/11/2022
Account next due 31/08/2024
Latest return 09/09/2015
Return next due 07/10/2016
Type of accounts SMALL
VAT Number /Sales tax ID GB202585333  
Last Datalog update: 2023-11-06 07:29:44
Primary Source:Companies House
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of METHUSELAH HEALTH UK LIMITED

Current Directors
Officer Role Date Appointed
THE CAMBRIDGE PARTNERSHIP LIMITED
Company Secretary 2014-09-09
DAVID JOHN GRAINGER
Director 2014-09-09
KEVIN STUART JOHNSON
Director 2018-04-06
RICHARD COLIN ST HELIER MASON
Director 2018-05-01
Previous Officers
Officer Role Date Appointed Date Resigned
FRANCESCO DE RUBERTIS
Director 2014-09-09 2018-04-06

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
THE CAMBRIDGE PARTNERSHIP LIMITED CRITICAL PRESSURE LIMITED Company Secretary 2017-06-20 CURRENT 2017-06-20 Active
THE CAMBRIDGE PARTNERSHIP LIMITED DC EUROPA LIMITED Company Secretary 2017-06-20 CURRENT 2017-06-20 Liquidation
THE CAMBRIDGE PARTNERSHIP LIMITED THE FOUNDRY (CAMBRIDGE) LIMITED Company Secretary 2017-06-16 CURRENT 2017-06-16 Active
THE CAMBRIDGE PARTNERSHIP LIMITED REBALANCE (CAMBRIDGE) LIMITED Company Secretary 2016-12-06 CURRENT 2016-12-06 Liquidation
THE CAMBRIDGE PARTNERSHIP LIMITED KYMO THERAPEUTICS LIMITED Company Secretary 2016-05-23 CURRENT 2016-05-23 Active
THE CAMBRIDGE PARTNERSHIP LIMITED CORRECTA4 BIO LIMITED Company Secretary 2016-04-19 CURRENT 2016-04-19 Liquidation
THE CAMBRIDGE PARTNERSHIP LIMITED SUPERX LIMITED Company Secretary 2015-11-10 CURRENT 2015-11-10 Liquidation
THE CAMBRIDGE PARTNERSHIP LIMITED HUMAN ANTIBODY FACTORY LIMITED Company Secretary 2015-10-06 CURRENT 2015-10-06 Liquidation
THE CAMBRIDGE PARTNERSHIP LIMITED CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Company Secretary 2015-07-15 CURRENT 2015-07-15 Active
THE CAMBRIDGE PARTNERSHIP LIMITED Z FACTOR LIMITED Company Secretary 2014-10-21 CURRENT 2014-10-21 Active
THE CAMBRIDGE PARTNERSHIP LIMITED FUNXIONAL THERAPEUTICS LIMITED Company Secretary 2014-09-01 CURRENT 2005-08-11 Dissolved 2017-12-12
THE CAMBRIDGE PARTNERSHIP LIMITED STX PHARMA LTD Company Secretary 2014-07-06 CURRENT 2012-10-19 Liquidation
THE CAMBRIDGE PARTNERSHIP LIMITED APCINTEX LIMITED Company Secretary 2014-06-16 CURRENT 2014-06-16 Active
THE CAMBRIDGE PARTNERSHIP LIMITED JANPIX LIMITED Company Secretary 2013-09-27 CURRENT 2013-09-27 Active - Proposal to Strike off
DAVID JOHN GRAINGER CRITICAL PRESSURE LIMITED Director 2017-10-02 CURRENT 2017-06-20 Active
DAVID JOHN GRAINGER DC EUROPA LIMITED Director 2017-06-20 CURRENT 2017-06-20 Liquidation
DAVID JOHN GRAINGER THE FOUNDRY (CAMBRIDGE) LIMITED Director 2017-06-16 CURRENT 2017-06-16 Active
DAVID JOHN GRAINGER REBALANCE (CAMBRIDGE) LIMITED Director 2016-12-06 CURRENT 2016-12-06 Liquidation
DAVID JOHN GRAINGER CORRECTA4 BIO LIMITED Director 2016-04-19 CURRENT 2016-04-19 Liquidation
DAVID JOHN GRAINGER HUMAN ANTIBODY FACTORY LIMITED Director 2015-10-06 CURRENT 2015-10-06 Liquidation
DAVID JOHN GRAINGER ABC MEDICINES LIMITED Director 2015-09-15 CURRENT 2015-09-15 Active - Proposal to Strike off
DAVID JOHN GRAINGER CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Director 2015-07-15 CURRENT 2015-07-15 Active
DAVID JOHN GRAINGER TOTAL DIAGNOSTICS LIMITED Director 2015-03-24 CURRENT 2015-03-24 Dissolved 2018-07-10
DAVID JOHN GRAINGER THE CAMBRIDGE PARTNERSHIP LIMITED Director 2014-11-01 CURRENT 2012-11-09 Active
DAVID JOHN GRAINGER Z FACTOR LIMITED Director 2014-10-21 CURRENT 2014-10-21 Active
DAVID JOHN GRAINGER FUNXIONAL THERAPEUTICS LIMITED Director 2014-09-01 CURRENT 2005-08-11 Dissolved 2017-12-12
DAVID JOHN GRAINGER PURPLE PHARMACEUTICALS LIMITED Director 2013-07-12 CURRENT 2013-07-12 Dissolved 2017-09-19
DAVID JOHN GRAINGER INHIBITAXIN LIMITED Director 2013-06-25 CURRENT 2013-06-25 Liquidation
DAVID JOHN GRAINGER ONCOMET LIMITED Director 2013-02-28 CURRENT 2013-02-28 Dissolved 2015-12-23
DAVID JOHN GRAINGER RXCELERATE LIMITED Director 2012-11-07 CURRENT 2012-11-07 Active
KEVIN STUART JOHNSON ULTRAHUMAN ONE LIMITED Director 2017-04-06 CURRENT 2017-02-28 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN THIRTEEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON LOCKBODY THERAPEUTICS LTD Director 2017-04-06 CURRENT 2017-03-03 Active
KEVIN STUART JOHNSON ULTRAHUMAN TWELVE LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN SEVEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON GRANULAR THERAPEUTICS LIMITED Director 2017-04-06 CURRENT 2017-03-03 Active
KEVIN STUART JOHNSON ULTRAHUMAN TEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN ELEVEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN FOURTEEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN TWO LIMITED Director 2017-04-06 CURRENT 2017-03-01 Active - Proposal to Strike off
KEVIN STUART JOHNSON ULTRAHUMAN THREE LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN FOUR LIMITED Director 2017-04-06 CURRENT 2017-03-03 Active - Proposal to Strike off
KEVIN STUART JOHNSON ULTRAHUMAN NINE LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN EIGHT LIMITED Director 2017-04-06 CURRENT 2017-03-03 Active
KEVIN STUART JOHNSON REBALANCE (CAMBRIDGE) LIMITED Director 2016-12-06 CURRENT 2016-12-06 Liquidation
KEVIN STUART JOHNSON SUPERX LIMITED Director 2016-01-07 CURRENT 2015-11-10 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN LIMITED Director 2015-12-16 CURRENT 2015-11-24 Liquidation
KEVIN STUART JOHNSON CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Director 2015-10-30 CURRENT 2015-07-15 Active
KEVIN STUART JOHNSON CRESCENDO BIOLOGICS LIMITED Director 2015-07-07 CURRENT 2007-11-13 Active
KEVIN STUART JOHNSON CAPELLA BIOSCIENCE LTD Director 2014-12-19 CURRENT 2014-11-07 Active
KEVIN STUART JOHNSON APCINTEX LIMITED Director 2014-06-16 CURRENT 2014-06-16 Active
KEVIN STUART JOHNSON LETSBEATSEPSIS Director 2014-05-19 CURRENT 2014-05-19 Active - Proposal to Strike off
KEVIN STUART JOHNSON INHIBITAXIN LIMITED Director 2013-06-25 CURRENT 2013-06-25 Liquidation
KEVIN STUART JOHNSON B3NGF LTD Director 2013-02-14 CURRENT 2013-02-14 Dissolved 2015-12-21
KEVIN STUART JOHNSON LEVICEPT LTD Director 2012-08-23 CURRENT 2012-08-23 Active
RICHARD COLIN ST HELIER MASON STX PHARMA LTD Director 2015-02-18 CURRENT 2012-10-19 Liquidation
RICHARD COLIN ST HELIER MASON CAMBRIDGE PROTEIN WORKS LIMITED Director 2013-12-30 CURRENT 2013-12-30 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2023-10-12CONFIRMATION STATEMENT MADE ON 01/10/23, WITH NO UPDATES
2023-08-08SMALL COMPANY ACCOUNTS MADE UP TO 30/11/22
2022-10-03CONFIRMATION STATEMENT MADE ON 01/10/22, WITH UPDATES
2022-10-03CS01CONFIRMATION STATEMENT MADE ON 01/10/22, WITH UPDATES
2022-09-16PSC02Notification of Rxcelerate Limited as a person with significant control on 2022-09-16
2022-09-16AA01Current accounting period extended from 30/09/22 TO 30/11/22
2022-09-16PSC09Withdrawal of a person with significant control statement on 2022-09-16
2022-09-16AP01DIRECTOR APPOINTED DR JILL RECKLESS
2022-09-16TM01APPOINTMENT TERMINATED, DIRECTOR DAVID EDER MOSEDALE
2022-03-18AP01DIRECTOR APPOINTED DR DAVID EDER MOSEDALE
2021-12-1630/09/21 ACCOUNTS TOTAL EXEMPTION FULL
2021-12-16AA30/09/21 ACCOUNTS TOTAL EXEMPTION FULL
2021-10-18TM01APPOINTMENT TERMINATED, DIRECTOR KEVIN STUART JOHNSON
2021-10-06CS01CONFIRMATION STATEMENT MADE ON 01/10/21, WITH NO UPDATES
2021-06-21AA30/09/20 ACCOUNTS TOTAL EXEMPTION FULL
2020-10-02AD01REGISTERED OFFICE CHANGED ON 02/10/20 FROM C/O the Cambridge Partnership Limited the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3AT United Kingdom
2020-10-01CS01CONFIRMATION STATEMENT MADE ON 01/10/20, WITH NO UPDATES
2020-09-22CS01CONFIRMATION STATEMENT MADE ON 09/09/20, WITH NO UPDATES
2020-08-27AD01REGISTERED OFFICE CHANGED ON 27/08/20 FROM Moneta Building Babraham Research Campus Babraham Cambridge Cambridgeshire CB22 3AT
2020-06-24AASMALL COMPANY ACCOUNTS MADE UP TO 30/09/19
2019-09-11TM01APPOINTMENT TERMINATED, DIRECTOR RICHARD COLIN ST HELIER MASON
2019-09-10CS01CONFIRMATION STATEMENT MADE ON 09/09/19, WITH NO UPDATES
2019-06-27AASMALL COMPANY ACCOUNTS MADE UP TO 30/09/18
2018-09-18CS01CONFIRMATION STATEMENT MADE ON 09/09/18, WITH NO UPDATES
2018-06-26AA30/09/17 ACCOUNTS TOTAL EXEMPTION FULL
2018-05-30AP01DIRECTOR APPOINTED DR RICHARD COLIN ST HELIER MASON
2018-04-20AP01DIRECTOR APPOINTED DR KEVIN STUART JOHNSON
2018-04-19TM01APPOINTMENT TERMINATED, DIRECTOR FRANCESCO DE RUBERTIS
2018-01-18CH01Director's details changed for Mr Francesco De Rubertis on 2017-11-20
2017-09-13CS01CONFIRMATION STATEMENT MADE ON 09/09/17, WITH UPDATES
2017-06-28AA30/09/16 ACCOUNTS TOTAL EXEMPTION SMALL
2017-06-21LATEST SOC21/06/17 STATEMENT OF CAPITAL;GBP 2
2017-06-21SH0129/03/17 STATEMENT OF CAPITAL GBP 2
2017-06-19RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of allotment of securities
2017-06-19RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2016-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / DR DAVID JOHN GRAINGER / 20/09/2016
2016-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR FRANCESCO DE RUBERTIS / 20/09/2016
2016-09-16CS01CONFIRMATION STATEMENT MADE ON 09/09/16, WITH UPDATES
2016-06-09AA30/09/15 ACCOUNTS TOTAL EXEMPTION SMALL
2015-09-21LATEST SOC21/09/15 STATEMENT OF CAPITAL;GBP 1
2015-09-21AR0109/09/15 ANNUAL RETURN FULL LIST
2015-01-15AD01REGISTERED OFFICE CHANGED ON 15/01/15 FROM C/O Index Venture Management Llp 3 Burlington Gardens Mayfair London W1S 3EP England
2014-09-09LATEST SOC09/09/14 STATEMENT OF CAPITAL;GBP 1
2014-09-09NEWINCNew incorporation
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to METHUSELAH HEALTH UK LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against METHUSELAH HEALTH UK LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
METHUSELAH HEALTH UK LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Filed Financial Reports
Annual Accounts
2015-09-30
Annual Accounts
2016-09-30
Annual Accounts
2017-09-30
Annual Accounts
2018-09-30
Annual Accounts
2019-09-30
Annual Accounts
2020-09-30
Annual Accounts
2021-09-30

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on METHUSELAH HEALTH UK LIMITED

Intangible Assets
Patents
We have not found any records of METHUSELAH HEALTH UK LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for METHUSELAH HEALTH UK LIMITED
Trademarks
We have not found any records of METHUSELAH HEALTH UK LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for METHUSELAH HEALTH UK LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as METHUSELAH HEALTH UK LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where METHUSELAH HEALTH UK LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded METHUSELAH HEALTH UK LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded METHUSELAH HEALTH UK LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.